Abstract:Since the first genome-wide association study on human age-related macular degeneration was reported by Science journal in 2005, a series of genome-wide association studies have been published on human complex diseases or traits, such as obesity, type 2 diabetes, coronary artery disease, Alzheimer's disease and so on. The study of human genetics has recently undergone a dramatic transition which is called "the first wave of genome-wide association study". Some issues in statistical analysis of genome-wide association studies were reviewed by this paper. First, statistical analysis guidelines, methods and examples for genome-wide association studies of different designs, including unrelated case-control studies, population-based studies, and family-based association studies; second, multiple testing correction of P values, including Bonferroni correction, step-down Bonferroni correction, permutation correction, and the correction based on false discovery rate; third, population stratification and its effect on inference of genotype-phenotype associations. The False Positive Re-port Probability has been successfully applied in a recent genome-wide association study on coronary artery disease to con-trol the population stratification. Although genetic statistical methodology has been greatly developed in control of false positive associations caused by multiple testing or population stratification, it is still not sufficient to achieve the goal. Replicating genotype-phenotype associations is the only way to identify true association between genetic markers and common disease traits. The first wave of genome-wide association studies is producing an impressive list of unexpected associations between genes or chromosomal regions and a broad range of diseases. Traditional statistical techniques are adequate for the analysis and interpretation of these results. However, much more sophisticated methods of statistical analysis are likely to be required as we delve further into the genome in the search for networks of interacting gene variants, or interactions be-tween gene-gene networks and environmental factors. Finally, some useful links about statistical software for genome-wide association studies were provided.

Ethical issues in the application of genome-wide association studies to US military recruitment and personnel assignments

Chinese geneticists' views of ethical issues in genetic testing and screening: evidence for eugenics in China

Genome-wide association studies: theoretical and practical concerns

A nation's genes for a cure to cancer: evolving ethical, social and legal issues regarding population genetic databases

Ethical and Policy Issues in Genetic Prediction of Violence: Implications for Clinicians

Genome-wide association study on complex diseases: genetic statistical issues]

Application of Partial Least Squares in Exploring the Genome Selection Signatures Between Populations.

Genome-wide association studies (GWAS) have revolutionized our view of human health and disease genetics and offered novel gene therapy targets

Enabling responsible public genomics

Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program

Legal aspects of privacy-enhancing technologies in genome-wide association studies and their impact on performance and feasibility

"Holy Cow, Where do I Sign up?" Attitudes of Military Veterans Toward Epigenomic Biomarker Toxic Exposure Testing

Ethical, legal, and social implications of genetic risk prediction for multifactorial disease: a narrative review identifying concerns about interpretation and use of polygenic scores

Ethical issues raised by new genomic technologies: the case study of newborn genome screening

Using human genetics to improve safety assessment of therapeutics

Interpreting disease genome‐wide association studies and polygenetic risk scores given eligibility and study design considerations

Research ethics and the challenge of whole-genome sequencing

Germline testing for veterans with advanced prostate cancer: concerns about service-connected benefits

Privacy in the Genomic Era

Genome editing in clinical genetics: points to consider—a statement of the American College of Medical Genetics and Genomics

Genetics of Post-Traumatic Stress Disorder: Review and Recommendations for Genome-Wide Association Studies